- Home
- Companies
- IntraOp Medical, Inc.
- Applications
- Intraoperative Radiation Therapy (IORT) ...
Intraoperative Radiation Therapy (IORT) System for Surgical Oncologists - Medical / Health Care - Clinical Services
For surgical oncologists, Mobetron serves a critical collaborative role in efficiently and effectively delivering an ablative dose of radiation directly to the tumor bed at the optimal biological time. It ensures confidence among surgical specialists that microscopic and residual cancers have been effectively treated.
In its most recent APBI Consensus Statement, ASTRO offered “published evidence complemented by expert opinion” in distinguishing Mobetron from all other IORT treatment options available in the fight against breast cancer. In fact, electron IORT — as performed with the Mobetron— is the only single treatment radiation option for suitable patients affirmed by the ASTRO consensus.
By enabling truly patient-specific treatment among surgeons and radiation oncologists, Mobetron improves efficiency by reducing treatment from weeks to minutes. And it gets entire surgical teams into the OR and up and running quickly. Faster treatment times mean fewer personnel are required and a greater number of patients may be treated. All of this equates to being able to focus on increased productivity and maximizing economics.
Time is critical and shorter treatment times deliver a host of benefits. But it doesn’t end there. Mobetron is also the tool that surgical teams can configure for their most efficient workflows. Mobetron’s thin-walled applicators provide virtually no dose to the skin and may be conformed to a variety of anatomical structures and tumor geometries. With field sizes ranging from 3 cm to 20 cm and treatment depths of up to 4 cm, Mobetron is simply the most flexible and powerful IORT device available.
Maximized Therapeutic Ratio:
- Dose Uniformity and Configurability
- Minimally Invasive
- Improved Radiobiologic Effect: Single Fraction IORT has 2-3 times biologic impact of fractioned radiation therapy (Haddock, et, al 1999)
Optimized for the OR:
- Multiple Variable Applicators
- Precise Soft Docking Alignment
- Single Sterile Environment
Proven Outcomes for Patients:
- 15,000 Patients Worldwide
- Twenty Years of Clinical Data
- Highly Conducive to Oncoplasty